• Select Your Topic Then Scroll Down
    Alcohol Bupe Benzos
    Cocaine Heroin Opioids
    RCs Stimulants Misc
    Harm Reduction All Topics Gabapentinoids
    Tired of your habit? Struggling to cope?
    Want to regain control or get sober?
    Visit our Recovery Support Forums

Which is more damaging; Cannabis or Heroin? [split from DC]

Status
Not open for further replies.
Originally posted by Blowmonkey
What does this has got to do with it? I could say the same about opiate users, but I don't because I know it's a stupid generalisation


That statement was taken out of context from an ongoing debate Glogga and I have been having.
 
Originally posted by gloggawogga
I never made any such implication.


But I think pot smokers are quite correct in assessing that heroin and meth are more dangerous than pot.


Well then we will never come to an agreement because that is incorrect and I will always believe it to be.
 
There are more recorded deaths from heroin and meth then there are from cannabis (no recorded deaths as far as I'm concerned).
 
I am only concerned with heroin; I don't want to throw meth into this conversation because I agree that it is very harmful. Most (actually, almost ALL) fatal heroin OD's people don't have especially large amounts of morphine in their blood. That's because in most fatal OD's, there are other drugs involved - specifically alcohol and / or benzos. So no, it's not heroin alone.
 
re: Heroin vs. Weed

I think a lot of it has to do with culture. Most cannabis users approach it as a benign substance, at the very most comparable to alcohol in it's risks.

I've found that a lot of heroin users first approach the drug buying into at least some of the HUGE stigma about H.

In some cases it's part of the motivation and what makes it exciting, and I think the reason that a lot of people spiral out of control on H is that most people (given the commonsensical view of the drug) would need to be pretty out of control in the first place to risk doing a "deathtrap drug" like that.

My point is - if something is perceived as a deadly road to slow suicide then it will attract people looking to head down that road. That doesn't mean all heroin users are like that, it just skews the statistics a lot.

Most of the people I know in person who use smack more or less believe they are destroying themselves, but can't or don't want to stop. It doesn't have to be like that, but the image people have of this drug makes it a first stop for the self destructive.

--- G.
 
gloggawogga said:
There is conflicting evidence, a fair amount of which is steeped in drug war bias both for and against. Interestingly though, I didn't find much conflict in regards to the medical research on neuroprotective properties of cannabanoids.


Perfect. Thanks.
 
paradoxcycle said:
Originally posted by gloggawogga
I never made any such implication.


But I think pot smokers are quite correct in assessing that heroin and meth are more dangerous than pot.


Well then we will never come to an agreement because that is incorrect and I will always believe it to be.

How could you possibly?

I find the fact that you believe that extremely surprising. This comming from a guy experienced in all 3 areas.. I havent done meth, but ive tweaked off of meth bombs sold as MDxx..and ive done several opiates.

Do i even need to bring up why opiates and meth are worse than pot in addiction, dependancy, long term effects? Come on dude..

Im probably the most pot-addicted person living today, its like crack to me, little green rocks, you know? And I would never trade my pot use for one of those two..not in a million fuckin years..
 
paradoxcycle said:
Originally posted by gloggawogga
I never made any such implication.


But I think pot smokers are quite correct in assessing that heroin and meth are more dangerous than pot.


Well then we will never come to an agreement because that is incorrect and I will always believe it to be.
Paradoxcycle, a few minutes of fact-checking on Pub-Med shows that both heroin and meth are pretty dangerous.

Int J Neurosci. 2004 Aug;114(8):1001-11.
Opioid neurotoxicity: comparison of morphine and tramadol in an experimental rat model.

Atici S, Cinel L, Cinel I, Doruk N, Aktekin M, Akca A, Camdeviren H, Oral U.

Department of Anesthesiology & Reanimation, Mersin University School of Medicine, Mersin, Turkey. [email protected]


Histopathologic changes in rat brain due to chronic use of morphine and/or tramadol in progressively increased doses were investigated in this study. Thirty male Wistar rats (180-220 g) were included and divided into three groups. Normal saline (1 ml/kg) was given intraperitoneally as placebo in the control group (n = 10). Morphine group (n = 10) received morphine intraperitoneally at a dose of 4 mg/kg/day for the first 10 days, 8 mg/kg/day between 11-20 days, and 12 mg/kg/day between 21-30 days. The tramadol group (n = 10) received the drug intraperitoneally at doses of 20, 40, and 80 mg/kg/day in the first, second, and the third 10 days of the study, respectively. All rats were decapitated on the 30th day and the brain was removed intact for histology. The presence and the number of red neurons, which are a histologic marker of apoptosis, were investigated in the parietal, frontal, temporal, occipital, entorhinal, pyriform, and hippocampal CA1, CA2, CA3 regions. Red neurons were found in morphine and tramadol groups but not in the control group. The total number of red neurons was not different in morphine and tramadol groups, but the numbers of red neurons were significantly higher in the temporal and occipital regions in tramadol group as compared with the morphine group (p < .05). In conclusion, chronic use of morphine and/or tramadol in increasing doses is found to cause red neuron degeneration in the rat brain, which probably contributes to cerebral dysfunction. These findings should be taken into consideration when chrome use of opioids is indicated
This report surprised me. This is one of the few studies I know of that actually shows opiate-induced neurotoxicity. The dosages the rats were exposed to seem realistic compared to what a human user would expose himself to. I don't know of any reports that show neurotoxicity in humans directly related to opiate use, but the next case study suggests this possibility.

CMAJ • January 25, 2000; 162 (2)
© 2000 Canadian Medical Association or its licensors
ReviewSynthèse
Chasing the dragon - neurological toxicity associated with inhalation of heroin vapour: case report
Michael D. Hill*, Perry W. Cooper{dagger} and James R. Perry*

From the Divisions of *Neurology and {dagger}Neuroradiology, Sunnybrook and Women's College Health Sciences Centre, Sunnybrook Site, Toronto, Ont.

Case

A 33-year-old white man was admitted to a Toronto hospital after being found in an unresponsive state by his sister. He was a known drug abuser and had a history of heroin and cocaine use. It was known that he took his heroin not by injection but by inhalation of heated heroin vapours, a method known as "chasing the dragon." He had last been seen well 3 days previously and had spent the intervening period in bed for unknown reasons.

The patient was intubated at the scene by paramedics and had a Glasgow coma score of 6 upon admission. He was tachypneic (38 breaths/min) but hemodynamically stable, with blood pressure of 150/95 mm Hg, normal sinus rhythm and temperature of 38°C. Neurological examination revealed that he was comatose, unresponsive to verbal or painful stimuli. His pupils were both 4 mm in diameter and reactive, and the fundi were normal. Eye movements were conjugate but roving. Corneal reflexes were present bilaterally. The face was symmetric. The breathing pattern was fast but regular. Motor examination revealed axial myoclonus involving the neck flexors, the pectoral muscles and the abdominal musculature. The patient was diffusely hypotonic, and the limbs withdrew symmetrically on painful stimuli. Reflexes were 1+ throughout, but bilateral Babinski signs were present. General examination revealed no cardiac murmurs, a clear chest and normal abdomen. No needle marks were seen.

Head CT revealed bilateral hypoattenuated regions in the pallidum. Brain MRI demonstrated diffusely abnormal areas of increased T2 signal intensity involving the deep white matter of both cerebral hemispheres and the cerebellum (Fig. 1). Magnetic resonance angiography demonstrated normal proximal cerebral circulation. Electroencephalography demonstrated diffuse bilateral moderate-voltage theta and delta activity without epileptiform abnormalities. Carbon monoxide was undetectable in the serum. Lumbar puncture showed entirely normal cerebrospinal fluid indices. Chest radiography revealed no pulmonary disease. Creatine kinase was significantly elevated, to 32 930 U/L, with no myoglobinuria. The result of HIV serologic testing was negative. The heroin metabolites O6-monoacetylmorphine and morphine were present in the urine.1 Results of tests for cocaine metabolites and other toxic agents were negative.
The guy in this case report obviously ODd. Brain scans showed some abnormal activity. No surprise here. The report goes on to suggest that he shows signs of "Toxic leukoencephalopathy" due to his method of injesting heroin. Unfortunately, I could find no reports of how common this form of brain damage is in heroin users.
The evidence that meth causes brain damage is much more convincing.
Neurology. 2000 Mar 28;54(6):1344-9. Related Articles, Links

Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study.

Ernst T, Chang L, Leonido-Yee M, Speck O.

Department of Neurology, Harbor-UCLA Medical Center, Torrance, CA 90502, USA. [email protected]

OBJECTIVE: To determine whether proton MRS (1H MRS) can detect long-term metabolite abnormalities in abstinent methamphetamine users. BACKGROUND: Methamphetamine is toxic to dopaminergic and serotonergic neurons in rodents; however, little data are available on the toxic effects of methamphetamine on the human brain. METHODS: 1H MRS was performed in 26 abstinent methamphetamine abusers with a history of methamphetamine dependence (median total cumulative lifetime exposure, 3,640 g; median recency of last methamphetamine use, 4.25 months) and 24 healthy subjects without a history of drug abuse. Cerebral metabolite concentrations on 1H MRS were measured in the frontal cortex, frontal white matter, and basal ganglia. RESULTS: The concentration of N-acetylaspartate ([NA]), a neuronal marker, was reduced significantly (-5 to -6%) in the basal ganglia and frontal white matter of methamphetamine users compared with control subjects. The frontal white matter [NA] correlated inversely with the logarithm of the lifetime methamphetamine use. The methamphetamine users also showed significantly reduced total creatine in the basal ganglia (-8%), and increased choline-containing compounds ([CHO], +13%) and myo-inositol ([MI], +11%) in the frontal grey matter. CONCLUSIONS: The reduced [NA] on 1H MRS provides evidence for long-term neuronal damage in abstinent methamphetamine users.

PMID: 10746608 [PubMed - indexed for MEDLINE]
In English, the meth users in this study have large-scale brain damage.

Neurosci Biobehav Rev. 2004 Jan;27(8):821-6. Related Articles, Links
Click here to read Click here to read
Amphetamine neurotoxicity: accomplishments and remaining challenges.

McCann UD, Ricaurte GA.

Department of Psychiatry, School of Medicine, The Johns Hopkins University, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA. [email protected]

In addition to the social, cultural and indirect medical complications of amphetamine analog abuse, this class of drugs is also known to have the potential to damage brain monoaminergic cells directly. Using methamphetamine as a prototype, this article provides a brief review of the history of amphetamine neurotoxicity research and the progress that has been made toward defining its characteristics. Remaining challenges for this line of investigation are outlined, and suggested avenues for addressing these challenges are provided.
A literature review of numerous studies showing meth-induced neurotoxic brain damage.
Publication Types:

* Historical Article
* Review
* Review, Tutorial

Harv Rev Psychiatry. 2005 May-Jun;13(3):141-54. Related Articles, Links
Click here to read Click here to read
Implications of chronic methamphetamine use: a literature review.

Meredith CW, Jaffe C, Ang-Lee K, Saxon AJ.

Department of Psychiatry and Behavioral Sciences, University of Washington, and VA Puget Sound Health Care System (S-116 ATC), 1160 S. Columbian Way, Seattle, WA 98108, USA. [email protected]

Methamphetamine (MA) abuse is increasing to epidemic proportions, both nationally and globally. Chronic MA use has been linked to significant impairments in different arenas of neuropsychological function. To better understand this issue, a computerized literature search (PubMed, 1964-2004) was used to collect research studies examining the neurobiological and neuropsychiatric consequences of chronic MA use. Availability of MA has markedly increased in the United States due to recent technological improvements in both mass production and clandestine synthesis, leading to significant public health, legal, and environmental problems. MA intoxication has been associated with significant psychiatric and medical comorbidity. Research in animal models and human subjects reveals complicated mechanisms of neurotoxicity by which chronic MA use affects catecholamine neurotransmission. This pathology may underlie the characteristic cognitive deficits that plague chronic MA users, who experience impairments in memory and learning, psychomotor speed, and information processing. These impairments have the potential to compromise, in turn, the ability of MA abusers to engage in, and benefit from, psychosocially based chemical-dependency treatment. Development of pharmacological interventions to improve these cognitive impairments in this population may significantly improve the degree to which they may be able to participate in treatment. Atypical antipsychotics may have some promise in this regard.
Another lit-review documenting permanent brain damage in meth users.
To summarize, there's a small amount of research suggesting opiate-induced neurotoxicity. Still not enough to convince me that the average herion user is giving himself brain damage, but something worth thinking about. The effects heroin on the quality of life and psychology are better documented.
The scientific evidence that meth causes severe brain damage is extremely convincing.
It's not really fair for me to pick on heroin and meth without mentioning marijuana. Here's an abstract from a literature review of the harmful effects of marijuana.
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Aug;28(5):849-63. Related Articles, Links
Click here to read Click here to read
Adverse effects of cannabis on health: an update of the literature since 1996.

Kalant H.

Department of Pharmacology, Medical Sciences Building, University of Toronto, Toronto, ON, Canada M5S 1A8. [email protected]

Recent research has clarified a number of important questions concerning adverse effects of cannabis on health. A causal role of acute cannabis intoxication in motor vehicle and other accidents has now been shown by the presence of measurable levels of Delta(9)-tetrahydrocannabinol (THC) in the blood of injured drivers in the absence of alcohol or other drugs, by surveys of driving under the influence of cannabis, and by significantly higher accident culpability risk of drivers using cannabis. Chronic inflammatory and precancerous changes in the airways have been demonstrated in cannabis smokers, and the most recent case-control study shows an increased risk of airways cancer that is proportional to the amount of cannabis use. Several different studies indicate that the epidemiological link between cannabis use and schizophrenia probably represents a causal role of cannabis in precipitating the onset or relapse of schizophrenia. A weaker but significant link between cannabis and depression has been found in various cohort studies, but the nature of the link is not yet clear. A large body of evidence now demonstrates that cannabis dependence, both behavioral and physical, does occur in about 7-10% of regular users, and that early onset of use, and especially of weekly or daily use, is a strong predictor of future dependence. Cognitive impairments of various types are readily demonstrable during acute cannabis intoxication, but there is no suitable evidence yet available to permit a decision as to whether long-lasting or permanent functional losses can result from chronic heavy use in adults. However, a small but growing body of evidence indicates subtle but apparently permanent effects on memory, information processing, and executive functions, in the offspring of women who used cannabis during pregnancy. In total, the evidence indicates that regular heavy use of cannabis carries significant risks for the individual user and for the health care system.
So, the part about a 7-10% behavioral and physical addiction rate surprises me. I haven't read the entire aritcle or the studies it reviews, so I don't know what to make of that figure. For example, how do they define "physical addiction?" So, there are some dangers related to pot smoking, but overall, pot smoking is much safer that using meth or heroin.

edited the smilies out, again
 
Last edited by a moderator:
^I never disputed the fact that methamphetamine is neurotoxic; you didn't need to supply those links. I am very sceptical of the opiate/opioid studies though.

Originally posted by RollinWitAcoldBilly
How could you possibly?


Because I am living proof that one can use heroin on a regular basis and maintain a "normal" life. I don't really care if you think your pot addiction is acceptable and my heroin use is not. It is irrelevant.

I think the distinction between 'hard' and 'soft' drugs is a useless, simplistic and misleading media driven generalization. There are many factors which determine how "bad" different drugs are for you, and categorizing the multitude of levels of addiction (both physical and mental) and possible short and long term damage into only two categories is over simplification at its worst. For example, from all that is known about alcohol, from its potential for abuse and psychological addiction, it should be considered a hard drug, but because of centuries of acceptance by the majority such a classification would never pass.
 
But don't you have a lot of "down time" from heroin use? When I've used heroin, I've found that I couldn't get much of anything done for up to 24 hours. My memories during heroin use are very foggy as well. Alcohol (moderate dose) is out of the system much faster so it's easier to function normally. Marijuana leaves me with kind of a hangover for several days. Maybe "stupid-over" is a good way to describe it.
I just edited my previous post and added a marijuana study.
BTW, alcohol is definitely neurotoxic and physically addictive. A hard-core alcoholic who quits drinking cold turkey will actually die from the withdrawal symptoms.
 
Last edited:
Morrison's Lament said:
But how did you feel when you started? Hopeful? Optimistic?

--- G.

Sort of; happy that I had found such an incredible thing to do with my time while at the same time not having used long enough to experience negatives yet.

Thank god the connection ran out..id probably have been on oxy for the past week other wise and therefore hooked.. :(

I loved the shit so much at the time that I did not realize this..
 
paradoxcycle said:
^I never disputed the fact that methamphetamine is neurotoxic; you didn't need to supply those links. I am very sceptical of the opiate/opioid studies though.

Originally posted by RollinWitAcoldBilly
How could you possibly?


Because I am living proof that one can use heroin on a regular basis and maintain a "normal" life.

I suppose if you just look at the effects on day to day life, heroin could be somewhat on the same level of danger as weed.

Assuming you dont use everyday and dont go through withdrawls. However; the fact that you have managed to avoid the other dangers of heroin does not mean that they are not there, and completely able to hit you and everyone else at any point in time.

Complete change in personality and attitude towards loved ones, painful almost crippling withdrawl, stealing to fix, severe and looong lasting depression, lost sense of wholeness..i could go on all day..the list goes on..

Pot, unlike heroin, does not share those side effects..the worst you could experience from it is lazyness, irritability, insomnia, and decreased apetite. Bad memory and a general foggyness but these ALL PASS within 2 or 3 weeks of abstinance.

Not to mention that heroin and all opiates cost a fucking boat ass load of money to maintain, and pot, on the other hand is very, very cheap in comparison. And you can fucking die from over dosing it. Die. DIE! What will too much pot make you do? Go to sleep for like 14 hours? LOL

Im sorry I just find it impossible to accept that pot is as dangerous as heroin.. speed is maybe debatable..maybe.

The fact you maintain a normal life while frequently using heroin does not mean its not one of the most dangerous drugs in existance, man. Weed isnt just weed as most people say, BUT IT IS NOT HEROIN..
 
Last edited:
socko said:
For example, how do they define "physical addiction?"

As an addicting substance which has a physical withdrawal syndrome when the use is stopped, with cannabis it includes; restlessness, irritability, mild agitation, insomnia, sleep EEG disturbance, nausea, and cramping.
 
Blowmonkey said:
As an addicting substance which has a physical withdrawal syndrome when the use is stopped, with cannabis it includes; restlessness, irritability, mild agitation, insomnia, sleep EEG disturbance, nausea, and cramping.
Thanks for that info. Sorry about the smilies. I'll do a better job proofreading next time.
 
Originally posted by RollinWitAcoldBilly
Complete change in personality and attitude towards loved ones, painful almost crippling withdrawl, stealing to fix, severe and looong lasting depression, lost sense of wholeness..i could go on all day..the list goes on..


That's a complete load of bullshit. You have no idea what you're talking about. I am so fucking sick of this "pot isn't even a drug, man" bullshit. I refuse to argue any further when you're making such blatant generalizations.
 
More stuff on possible morphine/heroin nuerotoxicity, and one on methadone too:


J Neurosci. 2002 Sep 1;22(17):7650-61.
Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism.

Mao J, Sung B, Ji RR, Lim G.

Massachusetts General Hospital Pain Center, Department of Anesthesia and Critical Care, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA. [email protected]

Tolerance to the analgesic effect of an opioid is a pharmacological phenomenon that occurs after its prolonged administration. Activation of the NMDA receptor (NMDAR) has been implicated in the cellular mechanisms of opioid tolerance. However, activation of NMDARs can lead to neurotoxicity under many circumstances. Here we demonstrate that spinal neuronal apoptosis was induced in rats made tolerant to morphine administered through intrathecal boluses or continuous infusion. The apoptotic cells were predominantly located in the superficial spinal cord dorsal horn, and most apoptotic cells also expressed glutamic acid decarboxylase, a key enzyme for the synthesis of the inhibitory neurotransmitter GABA. Consistently, increased nociceptive sensitivity to heat stimulation was observed in these same rats. Mechanistically, the spinal glutamatergic activity modulated morphine-induced neuronal apoptosis, because pharmacological perturbation of the spinal glutamate transporter activity or coadministration of morphine with the NMDAR antagonist (+)-5-methyl-10,11-dihydro-5H-dibenzo [a,d] cyclohepten-5,10-imine maleate affected both morphine tolerance and neuronal apoptosis. At the intracellular level, prolonged morphine administration resulted in an upregulation of the proapoptotic caspase-3 and Bax proteins but a downregulation of the antiapoptotic Bcl-2 protein in the spinal cord dorsal horn. Furthermore, coadministration with morphine of N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (a pan-caspase inhibitor) or acetyl-aspartyl-glutamyl-valyl-aspart-1-aldehyde (a relatively selective caspase-3 inhibitor) blocked morphine-induced neuronal apoptosis. Blockade of the spinal caspase-like activity also partially prevented morphine tolerance and the associated increase in nociceptive sensitivity. These results indicate an opioid-induced neurotoxic consequence regulated by the NMDAR-caspase pathway, a mechanism that may have clinical implications in opioid therapy and substance abuse.




Neural activity associated with cognitive regulation in heroin users: A fMRI study.

Lee TM, Zhou WH, Luo XJ, Yuen KS, Ruan XZ, Weng XC.

Neuropsychology Laboratory, The University of Hong Kong, Hong Kong, PR China.

Previous research has found heroin addicts to be impulsive. This study employed functional magnetic resonance imaging technology to investigate the differences between heroin addicts and normal controls in neural activity associated with cognitive regulation of behavior. Twenty-one Chinese men participated in this study, 11 of whom were newly admitted heroin-addicted patients and 10 of whom were healthy volunteers. In the experimental task, the subjects were required to first identify the correct directions of arrowheads and then give the opposite answers. Behaviorally, the heroin-dependent patients took a much shorter time to complete the more demanding second part of the task but committed more errors than the normal controls. This pattern of behavior, characteristic of people who are disinhibited and who tend to be impulsive, was consistent with previous reports of impulsivity observed in people who have abused heroin. The neural activity of the patients that was associated with performing the experimental task of cognitive regulation was different to that of the normal controls in terms of the pattern of prefrontal activation, the attenuation of activity in the anterior cingulate, and the additional recruitment of the right inferior parietal region. This study is the first that seeks to understand the neural activity associated with impulsive behavior in people who abuse heroin. The pattern of imaging data obtained resembled the pattern of data observed in immature brains attempting to exercise cognitive control of behavior. Further theoretical and clinical implications of the findings are discussed.




Heroin abusers' performance on the Tower of London Test relates to the baseline EEG alpha2 mean frequency shifts.

Davydov DM, Polunina AG.

Department of Neuropsychology, Moscow Research Practical Center for Prevention of Drug Addiction, 156-368 Leninsky pr-t, Moscow 117571, Russia.

Planning function deficit is the most consistent finding in neuropsychological studies of heroin addicts. The performance on the Tower of London Test (TLT) correlated with the duration of daily heroin abuse (DDHA) in our previous study. Alpha2 mean frequency in anterior/central derivations was also predicted by DDHA in the same patient population. This retrospective study was undertaken in order to understand better the relationships between observed neurological deviations in heroin abusers. Thirty-three heroin addicts and 12 healthy males were evaluated with 14 neuropsychological tests and resting eyes-closed electroencephalography (EEG). Multivariate tests showed that performance on the difficult (five-move) problems of TLT was strongly predicted by the EEG alpha2 mean frequency shifts, and these relationships were generally mediated by chronic heroin length. However, post-hoc analyses at separate leads demonstrated that the relationships between cognitive variables and alpha2 mean frequencies in the left hemisphere were independent of chronic heroin effects, whereas elevation of alpha2 frequency in the right hemisphere was strongly predicted by chronic heroin intake length. The patients with extremely high alpha2 mean frequency at the left central region were especially prone to failure in TLT due to the inability of the hypothesized alpha2-generating network, which normally projects to the central and temporal derivations bilaterally and to the right posterior temporal derivation to function appropriately. Hence, it was concluded that planning dysfunction in heroin abusers is related to alpha2 mean frequency shifts predominantly at the central regions.




Prog Neuropsychopharmacol Biol Psychiatry. 2004 Nov;28(7):1109-15.

Long-term abstinence syndrome in heroin addicts: indices of P300 alterations associated with a short memory task.

Papageorgiou CC, Liappas IA, Ventouras EM, Nikolaou CC, Kitsonas EN, Uzunoglu NK, Rabavilas AD.

Psychophysiology Laboratory, Department of Psychiatry, Eginition Hospital, University of Athens Medical School, 74 Vas. Sophias Avenue, Athens, 11528, Greece. [email protected]

Attentional deficits have been implicated in the pathophysiology of opioid addicts. The P300 component of event-related potentials (ERPs) is considered as a manifestation of attentional operations. The authors' goal was the comparison of P300 elicited during a short memory test between subjects with prolonged heroin abstinence and current heroin users as well as healthy controls. The P300 component was evaluated during the anticipatory period of a short memory task in 20 patients characterized by a past history of opioid dependence (6 months abstinence), in 18 current heroin users and in 20 healthy comparison subjects, matched for age, sex and educational level. Abstinent heroin addicts exhibited significant reduction of P300 amplitude at central frontal region, relative to the other two groups. The findings are discussed in connection to the aim of identifying psychophysiological indices, addressing issues in opioid use disorders, and suggest that knowledge about cognitive operations, such as those reflected by P300 component, could provide further insight into psychophysiological mechanisms underlying the long-term abstinence state of heroin addicts.





Neuropsychopharmacology. 2000 Aug;23(2):113-26.
Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers.

Ornstein TJ, Iddon JL, Baldacchino AM, Sahakian BJ, London M, Everitt BJ, Robbins TW.

Department of Psychiatry, University of Cambridge School of Clinical Medicine, Addenbrookes Hospital, Cambridge, UK.

Groups of subjects whose primary drug of abuse was amphetamine or heroin were compared, together with age- and IQ-matched control subjects. The study consisted of a neuropsychological test battery which included both conventional tests and also computerised tests of recognition memory, spatial working memory, planning, sequence generation, visual discrimination learning, and attentional set-shifting. Many of these tests have previously been shown to be sensitive to cortical damage (including selective lesions of the temporal or frontal lobes) and to cognitive deficits in dementia, basal ganglia disease, and neuropsychiatric disorder. Qualitative differences, as well as some commonalities, were found in the profile of cognitive impairment between the two groups. The chronic amphetamine abusers were significantly impaired in performance on the extra-dimensional shift task (a core component of the Wisconsin Card Sort Test) whereas in contrast, the heroin abusers were impaired in learning the normally easier intra-dimensional shift component. Both groups were impaired in some of tests of spatial working memory. However, the amphetamine group, unlike the heroin group, were not deficient in an index of strategic performance on this test. The heroin group failed to show significant improvement between two blocks of a sequence generation task after training and additionally exhibited more perseverative behavior on this task. The two groups were profoundly, but equivalently impaired on a test of pattern recognition memory sensitive to temporal lobe dysfunction. These results indicate that chronic drug use may lead to distinct patterns of cognitive impairment that may be associated with dysfunction of different components of cortico-striatal circuitry.



Physiological and psychological effects of methadone in man.

Gritz ER, Shiffman SM, Jarvik ME, Haber J, Dymond AM, Coger R, Charuvastra V, Schlesinger J.

Methadone hydrochloride-maintenance outpatients were compared to abstinent exaddicts on physiological and psychological measures, and to normal subjects on physiological measures. The battery of psychological tests measure cognitive abilities and mental state. Methadone depressed respiration rate below other groups; abstinent subjects had higher heart rates than methadone or control subjects. No other physiological differences appeared. Electroencephalographic spectral analysis disclosed that the location of the alpha peak was at the lowest frequency in the methadone group, next lowest being the abstinent group. Discriminant functions based on a weighted combination of variables (frequencies) successfully distinguished the EEGs of the three groups. Both discriminant analysis and multiple regression analysis indicated that EEG changes were dose-dependent. Methadone subjects performed significantly poorer on several tests of learning and immediate recall compared to absitinent subjects.




Neuropsychobiology. 2002;45(2):67-73. Related Articles, Links

Opioid addiction changes cerebral blood flow symmetry.

Pezawas L, Fischer G, Podreka I, Schindler S, Brucke T, Jagsch R, Thurnher M, Kasper S.

Department of General Psychiatry, University of Vienna, Austria. Lukas.Peza

Changes in regional cerebral blood flow (rCBF) due to long-term abuse of opioids such as heroin or morphine are not yet fully understood in humans. The goal of the present study was to investigate rCBF alterations in a large sample of long-term opioid addicts in comparison to healthy controls. We investigated 21 opioid-dependent subjects, who were currently abusing heroin or were enrolled in a methadone or morphine maintenance program, and 36 healthy controls with (99m)Tc-HMPAO single photon emission computed tomography. We found a decrease in rCBF in most regions of interest in patients in comparison to controls. Long-term opioid dependence seems to decrease prefrontal CBF in particular. A right-greater-than-left CBF asymmetry in healthy subjects was reversed in patients. This change in CBF symmetry could reflect the different emotional status of opioid-dependent patients. Our findings are in line with neuropsychological investigations indicating a correlation of mood states with lateralization of hemispheric activation patterns. Copyright 2002 S. Karger AG, Basel


In summary, there is evidence the points to possible nuerotoxicity of opiods as well.
 
And just to juice things up a bit, some interesting information on possible opiod neuroprotection:

Crit Rev Neurobiol. 2004;16(4):271-302.

Morphinan neuroprotection: new insight into the therapy of neurodegeneration.

Zhang W, Hong JS, Kim HC, Zhang W, Block ML.

Neuropharmacology Section, Laboratory of Pharmacology and Chemistry, National Institute of Environmental Health Sciences/National Institutes of Health, Research Triangle Park, North Carolina 27709, USA. [email protected]

Neuro-inflammation plays a pivotal role in numerous neurodegenerative disorders, such as Parkinson's disease (PD). Traditional anti-inflammatory drugs have limited therapeutic use because of their narrow spectrum and severe side effects after long-term use. Morphinans are a class of compounds containing the basic morphine structure. The following review will describe novel neuroprotective effects of several morphinans in multiple inflammatory disease models. The potential therapeutic utility and underlying mechanisms of morphinan neuroprotection are discussed.



Synapse. 2004 Feb;51(2):83-90.
Morphine inhibits glutamate exocytosis from rat cerebral cortex nerve terminals (synaptosomes) by reducing Ca2+ influx.

Yang TT, Hung CF, Lee YJ, Su MJ, Wang SJ.

Department of Mental Health, Cardinal Tien Hospital, Taipei, Taiwan 231.

Morphine, a mu-opioid agonist, suppressed the Ca(2+)-dependent release of glutamate that was evoked by exposing cerebrocortical synaptosomes to the potassium channel blocker 4-aminopyridine. The presynaptic inhibition produced by morphine was concentration-dependent and blocked by the nonselective opioid receptor antagonist naloxone. As determined by examining the mechanism of mu-opioid receptor-mediated inhibition of glutamate release, morphine caused a significant reduction in 4-aminopyridine-evoked increase in the cytoplasmic free Ca(2+) concentration ([Ca(2+)](c)), but failed to alter both 4-aminopyridine-evoked depolarization of the synaptosomal plasma membrane potential and Ca(2+) ionophore (ionomycin)-induced glutamate release. In addition, morphine was not capable of producing further inhibition on 4AP-evoked glutamate release in synaptosomes pretreated with the cannabinoid CB(1) receptor agonist WIN 55212-2, which has been shown to depress glutamate release through a suppression of presynaptic voltage-dependent Ca(2+) channel activity. These data suggest that morphine exerts its inhibitory effect presynaptically, likely through the reduction of Ca(2+) influx into nerve terminals, and thereby inhibits the release of glutamate in the cerebral cortex. This may therefore indicate that mu-opioid receptor agonists have neuroprotective properties, especially in the excessive glutamate release that occurs under certain pathological conditions. Copyright 2003 Wiley-Liss, Inc.
 
Status
Not open for further replies.
Top